Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study

SIMPLE SUMMARY: Gemcitabine/nab-paclitaxel (GN) and FOLFIRINOX (FFX) are two standard first-line therapies for metastatic pancreatic cancer (PC) but have rarely been compared, especially in patients with locally advanced PC (LAPC). By carefully selecting patients, it is likely these two regimens lea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Williet, Nicolas, Petrillo, Angelica, Roth, Gaël, Ghidini, Michele, Petrova, Mila, Forestier, Julien, Lopez, Anthony, Thoor, Audrey, Weislinger, Lucie, De Vita, Ferdinando, Taieb, Julien, Phelip, Jean Marc
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8200096/
https://ncbi.nlm.nih.gov/pubmed/34199796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112797
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares